Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension

Alexander, 2001, Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension, Am. J. Physiol., Regul. Integr. Comp. Physiol., 280, R1388, 10.1152/ajpregu.2001.280.5.R1388 Bayorh, 2006, Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in Dahl salt-sensitive rats, Clin. Exp. Hypertens., 28, 121, 10.1080/10641960500468276 Bell, 2001, Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs, Am. J. Physiol. Heart Circ. Physiol., 281, H1704, 10.1152/ajpheart.2001.281.4.H1704 Beswick, 2001, Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response, Hypertension, 37, 781, 10.1161/01.HYP.37.2.781 Duka, 2001, Vasoactive potential of the B1 bradykinin receptor in normotension and hypertension, Circ. Res., 88, 275, 10.1161/01.RES.88.3.275 Elmarakby, 2003, Regulation of cardiovascular signaling by kinins and products of similar converting-enzyme systems: enalapril attenuates endothelin-1-induced hypertension via increased kinin survival, Am. J. Physiol. Heart Circ. Physiol., 284, H1899, 10.1152/ajpheart.00027.2003 Elmarakby, 2005, NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1, Hypertension, 45, 283, 10.1161/01.HYP.0000153051.56460.6a Griendling, 1994, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells, Circ. Res., 74, 1141, 10.1161/01.RES.74.6.1141 Hoagland, 2003, Contributions of 20-HETE to the antihypertensive effects of tempol in Dahl salt-sensitive rats, Hypertension, 41, 697, 10.1161/01.HYP.0000047881.15426.DC Ignjatovic, 2002, Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor, J. Biol. Chem., 277, 16847, 10.1074/jbc.M200355200 Kawada, 2002, A mouse model of angiotensin II slow pressor response: role of oxidative stress, J. Am. Soc. Nephrol., 13, 2860, 10.1097/01.ASN.0000035087.11758.ED Laursen, 1997, Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension, Circulation, 95, 588, 10.1161/01.CIR.95.3.588 Linz, 1995, Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors, Pharmacol. Rev., 47, 25 Loomis, 2005, Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled NOS in the rat aorta, J. Pharmacol. Exp. Ther., 315, 1058, 10.1124/jpet.105.091728 Lopez, 2003, Role of superoxide in modulating the renal effects of angiotensin II, Hypertension, 42, 1150, 10.1161/01.HYP.0000101968.09376.79 Makino, 2003, Increased renal medullary H2O2 leads to hypertension, Hypertension, 42, 25, 10.1161/01.HYP.0000074903.96928.91 Marceau, 1998, The B1 receptors for kinins, Pharmacol. Rev., 50, 357 Marin-Castano, 2002, Induction of functional bradykinin B1 receptors in normotensive rats and mice under chronic angiotensin-converting enzyme inhibitor treatment, Circulation, 105, 627, 10.1161/hc0502.102965 McLean, 2000, Kinin B1 receptors and the cardiovascular system: regulation of expression and function, Cardiovasc. Res., 48, 194, 10.1016/S0008-6363(00)00184-X Nickenig, 2002, The AT1-type angiotensin receptor in oxidative stress and atherogenesis: part II: AT1 receptor regulation, Circulation, 105, 530, 10.1161/hc0402.102619 Nishiyama, 2001, Systemic and regional hemodynamic responses to tempol in angiotensin II-infused hypertensive rats, Hypertension, 37, 77, 10.1161/01.HYP.37.1.77 Ortiz, 2001, Antioxidants block angiotensin II-induced increases in blood pressure and endothelin, Hypertension, 38, 655, 10.1161/01.HYP.38.3.655 Pasquie, 1999, Chronic bradykinin infusion and receptor blockade in angiotensin II hypertension in rats, Hypertension, 33, 830, 10.1161/01.HYP.33.3.830 Pollock, 2001, Evidence for endothelin involvement in the response to high salt, Am. J. Physiol., Renal Fluid Electrolyte Physiol., 281, F144, 10.1152/ajprenal.2001.281.1.F144 Pollock, 1998, Hypertensive response to chronic NO synthase inhibition is different in Sprague–Dawley rats from two suppliers, Am. J. Physiol., Regul. Integr. Comp. Physiol., 275, R1719, 10.1152/ajpregu.1998.275.5.R1719 Rajagopalan, 1996, Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone, J. Clin. Invest., 97, 1916, 10.1172/JCI118623 Reckelhoff, 2003, Role of oxidative stress in angiotensin-induced hypertension, Am. J. Physiol., Regul. Integr. Comp. Physiol., 284, R893, 10.1152/ajpregu.00491.2002 Rossi, 2002, Dual ACE and NEP inhibitor MDL-100, 240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor, J. Hypertens., 20, 1451, 10.1097/00004872-200207000-00034 Sasser, 2002, Renal endothelin in chronic angiotensin II hypertension, Am. J. Physiol., Regul. Integr. Comp. Physiol., 283, R243, 10.1152/ajpregu.00086.2002 Schnackenberg, 1999, Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha, Hypertension, 33, 424, 10.1161/01.HYP.33.1.424 Seccia, 2006, The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension, J. Hypertens., 24, 1419, 10.1097/01.hjh.0000234124.94013.ac Somers, 2000, Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt, Circulation, 101, 1722, 10.1161/01.CIR.101.14.1722 Sullivan, 2002, Altered nitric oxide synthase 3 distribution in mesenteric arteries of hypertensive rats, Hypertension, 39, 597, 10.1161/hy0202.103286 Tom, 2003, Bradykinin, angiotensin-(1–7), and ACE inhibitors: how do they interact?, Int. J. Biochem. Cell Biol., 35, 792, 10.1016/S1357-2725(02)00273-X Williams, 2004, Arterial pressure response to the antioxidant tempol and ETB receptor blockade in rats on a high-salt diet, Hypertension, 44, 770, 10.1161/01.HYP.0000144073.42537.06 Xu, 2004, Tempol lowers blood pressure and sympathetic nerve activity but not vascular O2− in DOCA-salt rats, Hypertension, 43, 329, 10.1161/01.HYP.0000112304.26158.5c Xu, 2005, Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction, Hypertension, 45, 747, 10.1161/01.HYP.0000153322.04859.81 Yusuf, 2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, N. Engl. J. Med., 342, 145, 10.1056/NEJM200001203420301 Zhang, 2004, ROS during the acute phase of Ang II hypertension participates in cardiovascular MAPK activation but not vasoconstriction, Hypertension, 43, 117, 10.1161/01.HYP.0000105110.12667.F8